Evidence map›Paper›PMID 22675465›Full record

ArticlePloS one2012

Nucleolin inhibits G4 oligonucleotide unwinding by Werner helicase.

Fred E Indig, Ivana Rybanska, Parimal Karmakar, Chakravarty Devulapalli, Haiqing Fu, France Carrier, Vilhelm A Bohr

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. The Nucleolus: In Genome Maintenance and Repair.International journal of molecular sciences · 2017
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The role of RecQ helicases in non-homologous end-joining.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Fred E IndigLaboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America. indigf@mail.nih.gov
Ivana Rybanska
Parimal Karmakar
Chakravarty Devulapalli
Haiqing Fu
France Carrier
Vilhelm A Bohr
National Institute on Aging · USUniversity of Maryland, Baltimore · USCenter for Cancer Research · USJadavpur University · INNational Institutes of Health · US

Funding

NIA/RRB Confocal Imaging FacilityZICAG000615 · NIA · NATIONAL INSTITUTE ON AGING · PI INDIG, FRED · 2009 to 2025
$17.9M
The Function of Werner Syndrome ProteinZIAAG000721 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 2009 to 2022
$7.7M
RADIATION INDUCED RNA BINDING PROTEINSR01GM057827 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI CARRIER, FRANCE · 1999 to 2002
$804k
Biomodulation of anticancer drugs targeting DNAR01CA116491 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI CARRIER, FRANCE · 2007 to 2009
$684k
Intramural NIH HHSNCI NIH HHS R01 1CA116491-01NCI NIH HHS R01 CA116491NIGMS NIH HHS R01 GM57827
6 · The paper itself

Abstract

backgroundThe Werner protein (WRNp), a member of the RecQ helicase family, is strongly associated with the nucleolus, as is nucleolin (NCL), an important nucleolar constituent protein. Both WRNp and NCL respond to the effects of DNA damaging agents. Therefore, we have investigated if these nuclear proteins interact and if this interaction has a possible functional significance in DNA damage repair. METHODOLOGY/PRINCIPAL

findingsHere we report that WRNp interacts with the RNA-binding protein, NCL, based on immunoprecipitation, immunofluorescent co-localization in live and fixed cells, and direct binding of purified WRNp to nucleolin. We also map the binding region to the C-terminal domains of both proteins. Furthermore, treatment of U2OS cells with 15 µM of the Topoisomerase I inhibitor, camptothecin, causes the dissociation of the nucleolin-Werner complex in the nucleolus, followed by partial re-association in the nucleoplasm. Other DNA damaging agents, such as hydroxyurea, Mitomycin C, and aphidicolin do not have these effects. Nucleolin or its C-terminal fragment affected the helicase, but not the exonuclease activity of WRNp, by inhibiting WRN unwinding of G4 tetraplex DNA structures, as seen in activity assays and electrophoretic mobility shift assays (EMSA). CONCLUSIONS/SIGNIFICANCE: These data suggest that nucleolin may regulate G4 DNA unwinding by WRNp, possibly in response to certain DNA damaging agents. We postulate that the NCL-WRNp complex may contain an inactive form of WRNp, which is released from the nucleolus upon DNA damage. Then, when required, WRNp is released from inhibition and can participate in the DNA repair processes.

Indexed as

G-QuadruplexesCamptothecinCell LineCell NucleolusExodeoxyribonucleasesHumansImmunoprecipitationNucleolinOligonucleotidesPhosphoproteinsProtein BindingProtein Interaction MappingProtein Structure, TertiaryProtein TransportRecombinant Fusion ProteinsRecQ HelicasesCamptothecinExodeoxyribonucleasesNucleolinOligonucleotidesPhosphoproteinsRecombinant Fusion ProteinsRecQ HelicasesRNA-Binding ProteinsWerner Syndrome HelicaseWRN protein, human

Identifiers

PMID22675465
PMCPMC3366963
OpenAlexW2057445890

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.